CRISPR

CRISPR1-mrpl4

ID
ZDB-CRISPR-260505-11
Name
CRISPR1-mrpl4
Previous Names
None
Target
Sequence
5' - GGGCTGGTGTCAAGTGAGCT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
The first two "G"s were added.
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
ouc501 mrpl4
ouc508 mrpl4
ouc509 mrpl4
ouc510 mrpl4
Expression
Gene expression in Wild Types + CRISPR1-mrpl4
No data available
Phenotype
Phenotype resulting from CRISPR1-mrpl4
No data available
Phenotype of all Fish created by or utilizing CRISPR1-mrpl4
Phenotype Fish Conditions Figures
intestine nfkbiab expression increased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 3 from Li et al., 2026
intestine tgfb1a expression increased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 3 from Li et al., 2026
enteroendocrine cell pyyb expression decreased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 2 from Li et al., 2026
yolk present, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 1 from Li et al., 2026
whole organism her15.1 expression decreased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 7 with image from Mo et al., 2023
intestine anterior region alpi.2 expression decreased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 2 from Li et al., 2026
intestinal bulb notch1a expression decreased distribution, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 7 with image from Mo et al., 2023
intestinal epithelial cell mitochondrion decreased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 4 from Li et al., 2026
whole organism decreased length, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 1 from Li et al., 2026
whole organism muc2.1 expression increased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 2 from Li et al., 2026
intestine structure, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 1,  Fig. S1 from Li et al., 2026
intestine anterior region slc15a1b expression decreased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 2 from Li et al., 2026
swim bladder uninflated, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 1,  Fig. S1 from Li et al., 2026
whole organism hey1 expression decreased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 7 with image from Mo et al., 2023
intestinal bulb Notch signaling pathway decreased process quality, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 7 with image from Mo et al., 2023
enteroendocrine cell decreased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 2 from Li et al., 2026
liver notch1a expression decreased distribution, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 7 with image from Mo et al., 2023
proton motive force-driven mitochondrial ATP synthesis decreased process quality, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 4 from Li et al., 2026
liver hey1 expression decreased distribution, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 7 with image from Mo et al., 2023
liver Notch signaling pathway decreased process quality, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 7 with image from Mo et al., 2023
intestinal bulb chia.1 expression decreased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 2 from Li et al., 2026
intestinal bulb hey1 expression decreased distribution, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 7 with image from Mo et al., 2023
whole organism agr2 expression increased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 2 from Li et al., 2026
whole organism decreased life span, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 1 from Li et al., 2026
intestine il1b expression increased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 3 from Li et al., 2026
intestine anterior region fabp2 expression decreased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 2 from Li et al., 2026
intestine lumen collapsed, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 1 from Li et al., 2026
goblet cell agr2 expression increased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 2 from Li et al., 2026
intestine inflammatory response increased occurrence, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 3 from Li et al., 2026
yolk increased size, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 1 from Li et al., 2026
whole organism notch1a expression decreased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 7 with image from Mo et al., 2023
whole organism mrpl4 expression decreased amount, abnormal mrpl4ouc501/ouc501 standard conditions Fig. EV5 with image from Mo et al., 2023
whole organism dead, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 1 from Li et al., 2026
intestinal bulb cell population proliferation decreased occurrence, abnormal mrpl4ouc501/ouc501 standard conditions Fig. 2 from Li et al., 2026
intestine structure, abnormal mrpl4ouc509/ouc509 standard conditions Fig. S1 from Li et al., 2026
swim bladder uninflated, abnormal mrpl4ouc509/ouc509 standard conditions Fig. S1 from Li et al., 2026
intestine structure, abnormal mrpl4ouc510/ouc510 standard conditions Fig. S1 from Li et al., 2026
swim bladder uninflated, abnormal mrpl4ouc510/ouc510 standard conditions Fig. S1 from Li et al., 2026
intestinal bulb epithelium nucleus structure, abnormal mrpl4ouc501/ouc501; cc4Tg standard conditions Fig. 3 from Li et al., 2026
intestinal bulb epithelium tight junction structure, abnormal mrpl4ouc501/ouc501; cc4Tg standard conditions Fig. 3 from Li et al., 2026
intestine neutrophil infiltrative, abnormal mrpl4ouc501/ouc501; cc4Tg; i114Tg standard conditions Fig. 3 from Li et al., 2026
intestine neutrophil increased amount, abnormal mrpl4ouc501/ouc501; cc4Tg; i114Tg standard conditions Fig. 3 from Li et al., 2026
intestinal bulb chia.1 expression decreased amount, abnormal mrpl4ouc501/ouc501; cq89Tg control Fig. 5 from Li et al., 2026
intestine anterior region slc15a1b expression decreased amount, abnormal mrpl4ouc501/ouc501; cq89Tg control Fig. 5 from Li et al., 2026
intestine morphology, ameliorated mrpl4ouc501/ouc501; cq89Tg heat shock Fig. 5 from Li et al., 2026
intestine anterior region alpi.2 expression amount, ameliorated mrpl4ouc501/ouc501; cq89Tg heat shock Fig. 5 from Li et al., 2026
intestine anterior region slc15a1b expression amount, ameliorated mrpl4ouc501/ouc501; cq89Tg heat shock Fig. 5 from Li et al., 2026
intestine anterior region fabp2 expression amount, ameliorated mrpl4ouc501/ouc501; cq89Tg heat shock Fig. 5 from Li et al., 2026
intestine anterior region alpi.2 expression decreased amount, abnormal mrpl4ouc501/ouc501; cq89Tg control Fig. 5 from Li et al., 2026
intestinal bulb chia.1 expression amount, ameliorated mrpl4ouc501/ouc501; cq89Tg heat shock Fig. 5 from Li et al., 2026
intestine anterior region fabp2 expression decreased amount, abnormal mrpl4ouc501/ouc501; cq89Tg control Fig. 5 from Li et al., 2026
intestine neutrophil amount, ameliorated mrpl4ouc501/ouc501; cq89Tg; i114Tg heat shock Fig. 5 from Li et al., 2026
intestine neutrophil increased amount, abnormal mrpl4ouc501/ouc501; cq89Tg; i114Tg control Fig. 5 from Li et al., 2026
Citations